Last $0.51 USD
Change Today 0.00 / 0.00%
Volume 0.0
ABMT On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 08/20/14 All times are local (Market data is delayed by at least 15 minutes).

advanced biomedical technolo (ABMT) Snapshot

Open
$0.51
Previous Close
$0.51
Day High
$0.51
Day Low
$0.51
52 Week High
07/7/14 - $1.00
52 Week Low
05/22/14 - $0.25
Market Cap
29.0M
Average Volume 10 Days
20.0
EPS TTM
$-0.02
Shares Outstanding
56.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ADVANCED BIOMEDICAL TECHNOLO (ABMT)

Related News

No related news articles were found.

advanced biomedical technolo (ABMT) Related Businessweek News

No Related Businessweek News Found

advanced biomedical technolo (ABMT) Details

Advanced BioMedical Technologies Inc., a development stage company, designs, develops, manufactures, and markets self-reinforced and re-absorbable biodegradable internal fixation devices. Its products include absorbable polyamide osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced BioMedical Technologies Inc. in March 2009. Advanced BioMedical Technologies Inc. was founded in 2002 and is based in New York, New York.

26 Employees
Last Reported Date: 02/13/14
Founded in 2002

advanced biomedical technolo (ABMT) Top Compensated Officers

Chief Executive Officer, Controller, Director...
Total Annual Compensation: $43.2K
President, Treasurer, Compliance Officer, Dir...
Total Annual Compensation: --
Chief Financial Officer, Secretary, Director ...
Total Annual Compensation: --
Compensation as of Fiscal Year 2013.

advanced biomedical technolo (ABMT) Key Developments

Advanced BioMedical Technologies, Inc. announced delayed 10-Q filing

On 06/12/2014, Advanced BioMedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Advanced BioMedical Technologies, Inc. announced delayed annual 10-K filing

On 01/28/2014, Advanced BioMedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2013

Advanced BioMedical Technologies, Inc. reported earnings results for the third quarter and nine months ended July 31, 2013. For the quarter, the company has posted net loss attributable to the common stockholders was $156,548, or $0 per share, compared to a net loss attributable to the common stockholders of $190,879, or $0 per share, for the same quarter ended July 31, 2012. Loss from operations was $113,226, compared to a loss from operations of $160,509, for the same quarter ended July 31, 2012. For the nine months, the company has posted net loss attributable to the common stockholders of $470,375, or $0.01 loss per share, compared to a net loss attributable to the common stockholders of $550,442, or $0.01 loss per share, for the same period ended July 31, 2012. Loss from operations was $346,022, compared to a loss from operations of $464,291, for the same period ended July 31, 2012.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ABMT:US $0.51 USD 0.00

ABMT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ABMT.
View Industry Companies
 

Industry Analysis

ABMT

Industry Average

Valuation ABMT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVANCED BIOMEDICAL TECHNOLO, please visit www.advbiomed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.